Documents
Application Sponsors
NDA 021737 | BAUSCH AND LOMB | |
Marketing Status
Application Products
001 | IMPLANT;INTRAVITREAL | 0.59MG | 1 | RETISERT | FLUOCINOLONE ACETONIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2004-11-04 | PRIORITY |
LABELING; Labeling | SUPPL | 7 | AP | 2007-10-30 | STANDARD |
EFFICACY; Efficacy | SUPPL | 10 | AP | 2008-08-05 | UNKNOWN |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 18 | AP | 2010-11-30 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 19 | AP | 2011-06-02 | N/A |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 21 | AP | 2014-06-20 | PRIORITY |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 22 | AP | 2015-03-30 | PRIORITY |
Submissions Property Types
ORIG | 1 | Orphan | 5 |
SUPPL | 10 | Null | 6 |
SUPPL | 18 | Null | 14 |
SUPPL | 19 | Null | 6 |
SUPPL | 21 | Null | 14 |
SUPPL | 22 | Null | 14 |
CDER Filings
BAUSCH AND LOMB
cder:Array
(
[0] => Array
(
[ApplNo] => 21737
[companyName] => BAUSCH AND LOMB
[docInserts] => ["",""]
[products] => [{"drugName":"RETISERT","activeIngredients":"FLUOCINOLONE ACETONIDE","strength":"0.59MG","dosageForm":"IMPLANT;INTRAVITREAL","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"06\/02\/2011","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/021737s019.pdf\"}]","notes":""},{"actionDate":"10\/30\/2007","submission":"SUPPL-7","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/021737s007lbl.pdf\"}]","notes":""},{"actionDate":"11\/04\/2004","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/021737lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"RETISERT","submission":"FLUOCINOLONE ACETONIDE","actionType":"0.59MG","submissionClassification":"IMPLANT;INTRAVITREAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
[supplements] =>
[actionDate] => 2011-06-02
)
)